VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus. - Wikidata - awgldk - TriplyDB

VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q40327375

about

Mechanisms of drug resistance: daptomycin resistance Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic review Bacterial lipids: metabolism and membrane homeostasis Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiers Strain Dependent Genetic Networks for Antibiotic-Sensitivity in a Bacterial Pathogen with a Large Pan-Genome Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis Streptococcus pyogenes polymyxin B-resistant mutants display enhanced ExPortal integrity.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.Evolving resistance among Gram-positive pathogens Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity.Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.A current perspective on daptomycin for the clinical microbiologist.Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.Effect of a small molecule Lipid II binder on bacterial cell wall stress.Methicillin-resistant Staphylococcus aureus: an evolving pathogen.Targeting cell membrane adaptation as a novel antimicrobial strategy.Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.Luciferase Reporter Gene System to Detect Cell Wall Stress Stimulon Induction in Staphylococcus aureus.Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics.Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.

P2860

Q26779944-B95FB0D6-2916-4931-9661-2A0F2CAF6E89 Q26796165-56F39D7A-A555-4AC8-908D-91D94DAF2615 Q26829512-B52BD862-ADAC-4EAD-B964-3DE2ED30AF28 Q26863225-4858B082-3A93-48E1-97A3-4E1EA586EA0E Q28541941-F51502A4-F24B-4A21-825F-84E89207F539 Q28553946-663D6312-2945-43CF-A6B9-987F1E316838 Q33579777-DA6D35BC-555B-4BC0-A1D4-83B5F63A5AF7 Q33899541-C78CDB84-BDC0-4215-B784-4C84F5CCC08A Q34405922-748D7FAC-CB56-4684-A10F-58E4CE9401C0 Q34597770-7AFFFB05-3D5C-4AAA-A67B-7A20A45E1C3F Q34648042-CA0FEF25-066E-49CC-86DA-B5198BCA5DFE Q34823364-76A2FB67-A037-477A-898C-55980E647EB9 Q35473516-8D2E83A5-D36D-441B-9714-D54A9DEF5795 Q35607659-80768CF3-53E4-440A-A2F2-625459F58548 Q35619094-F7047CD5-3CFC-4EE2-ABDB-6D5648847EB3 Q35746096-F3780D1D-FA02-4A58-B74D-EC46E83CE044 Q35999912-BC78F1EA-E75D-4D52-AA3D-B2272C8E1299 Q36158472-BFDC95F0-2B37-44C8-8BAE-10B5CCC664EC Q36200018-10765682-8A73-4C2E-B9B1-D21D2D9A4EB0 Q36290600-92E037F2-FFAC-4E35-8889-CBFEDDE5A72A Q36396117-D372BCE7-B930-4CD7-966F-8F29F404376C Q36505376-0DC829E2-5DF0-47D8-98C4-3F2E9AAC2AB3 Q36505489-DE2D3D3C-B660-4D24-B781-5615C6B31DFF Q37263289-17670A47-C2C6-4B72-8A6F-E4525135BBFE Q37263514-B3B0535E-9D91-414F-969A-E7D34B827465 Q37538754-E39D6067-8499-4EB3-B125-231D08A0B1D4 Q37682911-7B88FC52-E827-4F79-A0DD-77B71D10EC82 Q38171759-24FF585C-8884-4DEB-BA39-1FED9F7C3DF2 Q38908726-62DBE087-1B6D-4962-B281-0D29C83FD4E6 Q38942573-BF5FDEFA-2B11-4CDA-BCD0-394357C0930A Q40224178-C41E556A-BD09-4DDA-AB59-ABCC44806275 Q40264307-37E4C5FE-D21B-4141-B3AC-6B273554CC78 Q40333300-3A364D87-D7B9-4284-B19C-587EF268CB74 Q41874395-436B290D-D226-48C0-A3F9-CA27BDB4F3F4 Q41908540-B76AAE92-E3D5-4D26-B7E8-5A270D143CFC Q42102707-1B40EBC8-538E-4E41-A455-B163EBA50134 Q42202739-96D938E1-9019-43E1-A608-3982EB935F04 Q42280738-51B5A999-1741-4E2A-BBF9-DBEEE39A1C68 Q46240694-D95585BA-B311-486C-A12D-3B1CA5422C1D Q47116570-9DC203FD-1713-4371-9A7A-24FB29D13921

P2860

VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q40327375

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

VraSR two-component regulatory ...... sistant Staphylococcus aureus.

@en

type

label

VraSR two-component regulatory ...... sistant Staphylococcus aureus.

@en

prefLabel

VraSR two-component regulatory ...... sistant Staphylococcus aureus.

@en

P1433

Q40327375-146E8E9F-E9BD-46BE-8D46-C49BD3CCA6D9

P1476

Q40327375-44883C35-94AB-4D7A-975B-1352C4B617CE

P2093

Q40327375-3474A779-A575-40D7-B811-BAAE624B1D46

Q40327375-6A4D67AC-0F34-4F76-8AAC-1263D54E2EBE

Q40327375-71E7548E-A58A-4DB9-9233-A0664D937BE3

Q40327375-A6EDCFE2-5B06-4DFB-8D41-4C6845D50CE2

Q40327375-CF34E069-E6AF-4E4D-9835-C8BFDCFF30A5

Q40327375-D252A183-BDA7-4099-A3D8-F01961DEB178

Q40327375-F71A1390-AF12-4294-880E-F60AA3F885DD

P2860

Q40327375-097170A8-372D-4C89-9FCD-17E08A3E16AB

Q40327375-0AE5DEDF-7FE4-4B1A-9FCC-8E4232B7F5E5

Q40327375-0D857C84-6960-42B8-9624-78B631F63DF9

Q40327375-14E7C495-9998-48DC-A65F-5CAC951F4F04

Q40327375-162B84DA-CDC2-431A-9407-ACDFB29DAF6D

Q40327375-2540431E-9FDC-465D-A28A-345EC1E89325

Q40327375-26BBBD0B-07E6-4497-81DD-6B4BE94CF853

Q40327375-28268B31-5CC9-4809-8151-B69A8F8BC8F6

Q40327375-2A7178FF-79F2-4059-9ED4-4C09C9CA307F

Q40327375-2F42454F-C7A8-4983-B29E-D6A5BB4AA6BC

P304

Q40327375-C9905D4B-AC6C-4C7E-BB1E-C59E859D6B8D

P31

Q40327375-8764D0BB-02F3-43CD-B929-7E2BDD035C49

P356

Q40327375-FEC92645-2004-4770-B66F-2665234F4418

P407

Q40327375-F1480E1C-1238-4642-890A-5100D345B6D7

P433

Q40327375-08E919F6-5A9C-4F8A-9EA6-DD47BAF6F39A

P478

Q40327375-8A259C0D-6700-4F82-888B-75113C3D258D

P50

Q40327375-E626AE66-2711-4316-9D20-A8FD62992427

P577

Q40327375-09F2D928-3B60-4489-A834-DD0BF5FC9604

P698

Q40327375-76772054-BBB1-4537-BD36-E3E905B3C291

P921

Q40327375-46A8DC8C-D88A-4604-AE9E-7062E880E4B9

P932

Q40327375-0A71D92F-ADCE-489F-8C22-0F9EB58D739D

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

VraSR two-component regulatory ...... sistant Staphylococcus aureus.

@en

P2093

Aileen Rubio

http://www.w3.org/2001/XMLSchema#string

Arabela X Cuirolo

http://www.w3.org/2001/XMLSchema#string

Jared A Silverman

http://www.w3.org/2001/XMLSchema#string

Konrad B Plata

http://www.w3.org/2001/XMLSchema#string

Roberto R Rosato

http://www.w3.org/2001/XMLSchema#string

Sarah Riosa

http://www.w3.org/2001/XMLSchema#string

Shrenik Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

Correlating a protein structure with function of a bacterial mechanosensitive channel

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus

Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene

The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

P304

92-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00432-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Adriana E. Rosato

P577

2011-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21986832

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

3256076

http://www.w3.org/2001/XMLSchema#string